Johnson & Johnson is a global healthcare company that develops, manufactures, and markets a broad range of products across pharmaceuticals and medical technology. Its Innovative Medicine segment focuses on therapies in areas such as immunology, infectious diseases, neuroscience, oncology, and cardiovascular care, while its MedTech segment provides medical devices and solutions used in surgery, orthopedics, interventional procedures, and vision care. The company serves hospitals, clinicians, patients, and healthcare systems in markets around the world, making it a central participant in both drug development and medical device supply chains. Johnson & Johnson is known for operating at the intersection of large-scale research, clinical innovation, and essential healthcare delivery, with products that support prevention, treatment, diagnosis, and recovery across a wide range of medical settings.
Omsætning og resultat (USD)
Gns. kursmål: $279,82
Global Dermatological Therapeutics Market to Reach USD 97 Billion by 2034 | DelveInsight
GlobeNewswire Inc. · 28. okt. 2026

The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
Zacks Investment Research · 28. okt. 2026

4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
Zacks Investment Research · 27. okt. 2026
Johnson & Johnson is a global healthcare company that develops, manufactures, and markets a broad range of products across pharmaceuticals and medical technology. Its Innovative Medicine segment focuses on therapies in areas such as immunology, infectious diseases, neuroscience, oncology, and cardiovascular care, while its MedTech segment provides medical devices and solutions used in surgery, orthopedics, interventional procedures, and vision care. The company serves hospitals, clinicians, patients, and healthcare systems in markets around the world, making it a central participant in both drug development and medical device supply chains. Johnson & Johnson is known for operating at the intersection of large-scale research, clinical innovation, and essential healthcare delivery, with products that support prevention, treatment, diagnosis, and recovery across a wide range of medical settings.
Omsætning og resultat (USD)
Gns. kursmål: $279,82
Global Dermatological Therapeutics Market to Reach USD 97 Billion by 2034 | DelveInsight
GlobeNewswire Inc. · 28. okt. 2026

The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
Zacks Investment Research · 28. okt. 2026

4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
Zacks Investment Research · 27. okt. 2026